Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis
about
Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement.Current management of calcific aortic stenosis.Acute effects of sildenafil and dobutamine in the hypertrophic and failing right heart in vivo.Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials.Increased cardiac myocyte PDE5 levels in human and murine pressure overload hypertrophy contribute to adverse LV remodelingEmerging hemodynamic signatures of the right heart (Third International Right Heart Failure Summit, part 2).Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials.Protein kinase g positively regulates proteasome-mediated degradation of misfolded proteins.Sildenafil exposure and hemodynamic effect after Fontan surgeryManagement of pulmonary hypertension in left heart disease.Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): How do they work?Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis.
P2860
Q30355931-DF96C225-7C2A-49BC-93BD-C298B472B8B5Q30435363-DC7E5078-8B40-4B6B-AA48-0E0A1272E151Q33806059-6FED742A-6A13-45E2-BA19-F551C9208FD5Q34364927-AE3F7E40-6B48-41DB-88A7-16D1CC2A5E3EQ34634339-73594DAD-C18D-4D8A-BECE-1EEEE7473FCDQ34782638-4313F706-24F7-4672-AE03-5EBA844C7442Q36128551-BC32EB51-F0D0-4314-899C-6C5FB77C84D9Q37142904-96BFC384-6426-42DE-A678-512783DE972DQ37460315-6274AC94-F3F2-4BDD-9C5A-DA97A9052640Q38099630-62346C8B-3642-478F-A626-649337AB2D01Q38542767-43BEBA53-0D28-4E2C-9CF6-90902AA9D357Q44338340-36781A1F-9A00-41AF-BF94-5534B645691B
P2860
Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Effects of phosphodiesterase t ...... re symptomatic aortic stenosis
@ast
Effects of phosphodiesterase t ...... re symptomatic aortic stenosis
@en
type
label
Effects of phosphodiesterase t ...... re symptomatic aortic stenosis
@ast
Effects of phosphodiesterase t ...... re symptomatic aortic stenosis
@en
prefLabel
Effects of phosphodiesterase t ...... re symptomatic aortic stenosis
@ast
Effects of phosphodiesterase t ...... re symptomatic aortic stenosis
@en
P2093
P2860
P1433
P1476
Effects of phosphodiesterase t ...... re symptomatic aortic stenosis
@en
P2093
Alan Zajarias
Brian F Gage
Eric Novak
José A Madrazo
Mohammed Saghir
Murali M Chakinala
Stephanie N Johnson
Tara A Hohn
P2860
P304
P356
10.1161/CIRCULATIONAHA.111.081125
P407
P577
2012-03-25T00:00:00Z